9996 — Peijia Medical Balance Sheet
0.000.00%
- HK$3.59bn
- HK$3.30bn
- CNY615.48m
- 13
- 16
- 69
- 20
Annual balance sheet for Peijia Medical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2,461 | 2,296 | 1,741 | 943 | 713 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 36.3 | 23.7 | 69 | 69.7 | 101 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,544 | 2,426 | 2,007 | 1,237 | 987 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 107 | 176 | 327 | 499 | 696 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,881 | 3,164 | 3,316 | 2,672 | 2,689 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 44.4 | 119 | 578 | 154 | 443 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 68 | 144 | 679 | 398 | 661 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 2,813 | 3,019 | 2,638 | 2,274 | 2,028 |
| Total Liabilities & Shareholders' Equity | 2,881 | 3,164 | 3,316 | 2,672 | 2,689 |
| Total Common Shares Outstanding |